Pfizer’s Covid Booster Shot for Younger Teens Wins FDA Clearance, Stock Drops (But Pfizer Underperformed S&P 500 Index Since Fed COVID Stimulus)

#bubble, #inflation, @MetreSteven @JeffSnider_AIP @DiMartinoBooth @bondstrategist @RaoulGMI @LukeGromen @dlacalle_IA @EconguyRosie @profplum99 @SantiagoAuFund @biancoresearch @pboockvar @SriKGlobal, Banking, Pension, Powell, SPX, Stocks, Treasuries, Treasury, Uncategorized, Yellen 1 Minute

You would think that an FDA approval to give booster shots to millions of new patients would send their stock soaring. It didn’t Pfizer dropped along with the S&P 500 index.

Despite the growth of COVID cases in the US (blue dashed line), Pfizer stock has only gone up by “only” 88% since March 2020. The S&P 500 index rose by 100%.

I under what Pfizer’s performance would be if The Fed wasn’t blowing a hurricane wind at the back of the market.

Published by confoundedinterest17

Published